3rd Quarter - Report

CROSSROADS STRATEGIES, LLC for BRISTOL-MYERS SQUIBB

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to tax reform.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; FDA related issues.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5054 (114th), S. 2956 (114th)

Health Issues HCR

Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148) and the Food and Drug Administration Safety and Innovation Act (P.L.112-144). H.R.6, 21st Century Cures Act. Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program and Senate HELP Innovation Project.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Homeland Security HOM

Issues related to cybersecurity and data breach legislation.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid. H.R.5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models; issues related to Demonstration Programs.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5122 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.